Latest DEF 14A proxy statements

STAAR Surgical Company announced preliminary net sales of $94.7 million for Q3 2025, a 6.9% increase year-over-year, driven by a significant China shipment payment and growth outside China, despite reduced new orders from Chinese distributors.

Xilio Therapeutics will hold a special meeting on November 21, 2025, to vote on repricing underwater employee stock options and approving a new 2025 Stock Incentive Plan to address significant dilution and retain talent.

Crexendo, Inc. announced its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification, while highlighting significant operational and financial achievements.

Nabors Energy Transition Corp. II extends its deadline to complete a business combination by one month to November 18, 2025, supported by a $250,000 loan from an affiliate.

TransCode Therapeutics, Inc. filed an amendment to its Form 8-K/A, clarifying the effective date and rights agent for its Contingent Value Rights Agreement, which outlines future payments to shareholders from asset monetization.

OS Therapies Incorporated adjourned its 2025 annual meeting to October 21, 2025, to solicit additional proxies, while also releasing an investor presentation detailing its clinical pipeline and strategic milestones.

Tesla urges shareholders to approve the 2025 CEO Performance Award for Elon Musk, citing its importance for retaining his leadership and achieving ambitious growth targets.

LAVA Therapeutics N.V. shareholders are invited to an Extraordinary General Meeting on November 7, 2025, to vote on XOMA Royalty Corporation's amended tender offer of $1.04 cash plus one Contingent Value Right per share.

eGain Corporation has announced its Annual Meeting of Stockholders for December 9, 2025, where shareholders will vote on director elections, executive compensation, and auditor ratification.

Aviat Networks, Inc. has updated its proxy statement, reducing the number of additional shares requested for its 2018 Incentive Plan from 1.2 million to 800,000.

Great Elm Group, Inc. has filed definitive additional proxy materials with the U.S. Securities and Exchange Commission.

BlackRock MuniYield Pennsylvania Quality Fund's special shareholder meeting for a proposed fund combination has been adjourned to November 20, 2025, to allow more time for shareholder voting.

Mural Oncology plc reminds shareholders to vote on proposals for both the Scheme Meeting and Extraordinary General Meeting by October 23, 2025, concerning an acquisition.

BlackRock Long-Term Municipal Advantage Trust shareholders are urged to vote on a proposed fund combination, with the special meeting adjourned to November 20, 2025, promising potential benefits like increased after-tax yield and reduced expenses.

BlackRock California Municipal Income Trust (BFZ) shareholders are urged to vote on a proposed fund combination expected to increase after-tax yield and reduce expenses.

BlackRock Virginia Municipal Bond Trust has adjourned its special shareholder meeting to November 20, 2025, to allow more time for shareholders to vote on a proposed fund combination.

BlackRock Municipal Income Quality Trust shareholders are urged to vote on a fund combination expected to boost after-tax yield and reduce expenses.

Metsera's Board unanimously recommends stockholders approve the merger with Pfizer for $47.50 cash plus a contingent value right up to $22.50 per share, valuing the deal at a 110% premium.

BlackRock New York Municipal Income Trust urges shareholders to vote on a proposed fund combination expected to increase after-tax yield and reduce expenses.

Priority Income Fund, Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder votes.

BlackRock Investment Quality Municipal Trust, Inc. (BKN) urges shareholders to vote on a proposed fund combination, with the special meeting adjourned to November 20, 2025, citing expected expense reductions and other benefits.

Prospect Capital Corporation filed definitive additional proxy materials with the SEC under Section 14(a) of the Securities Exchange Act of 1934.

BlackRock MuniYield Quality Fund II, Inc. (MQT) shareholders are urged to vote on a proposed six-fund combination, with the special meeting adjourned to November 20, 2025.

BlackRock MuniYield Michigan Quality Fund, Inc. (MIY) adjourned its special shareholder meeting to November 20, 2025, to allow more time for voting on a proposed fund combination expected to increase after-tax yield and reduce expenses.

BlackRock MuniYield Fund (MYD) seeks shareholder approval for a proposed six-fund combination, projecting expense ratio declines, with the vote adjourned to November 20, 2025.

eGain Corporation announces its Annual Meeting of Stockholders on December 9, 2025, to elect directors, approve executive compensation, and ratify its independent auditor.

Xcel Brands, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 3, 2025, where key proposals include the election of five directors, an increase in shares for its equity incentive plan, and the ratification of a new independent accounting firm.

Gyrodyne, LLC announces its 2025 Annual Meeting to elect a director, approve executive compensation, and ratify auditors, following a resolved proxy contest.

Beyond Meat calls a Special Meeting to approve critical proposals, including a massive share increase and potential reverse stock split, following a significant debt exchange that caused substantial shareholder dilution.

Destiny Tech100 Inc. announced its annual shareholder meeting for November 28, 2025, to elect new directors and ratify KPMG as its auditor.